MORPHOSYS AG O.N. | 127.9000 / -0.16% |
Date/Time | 12/13 / 16:44 |
Chg. / Chg.(%) | -0.2000 / -0.16% |
Bid | 127.5000 / 100 |
Ask | 128.2000 / 100 |
Open | 128.6000 |
Previous Close | 128.1000 |
High | 130.1000 |
Low | 127.2000 |
Volume [EUR] | 163,559.9000 |
Volume [Units] | 1,270 |
Price fixings | 18 |
ISIN | DE0006632003 |
Security | MOR |
Exchange | Frankfurt |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 127.700 | ![]() |
|
Xetra | 127.90 | ![]() |
217,540 |
Cboe Europe .. | 127.80 | ![]() |
68,088 |
Turquoise | 127.80 | ![]() |
67,750 |
London Inter.. | 128.70 | ![]() |
25,219 |
Cboe Europe .. | 127.70 | ![]() |
19,493 |
TradeGate | 128.100 | ![]() |
11,757 |
Stuttgart | 127.700 | ![]() |
3,218 |
Frankfurt | 127.9000 | ![]() |
1,270 |
München | 128.70 | ![]() |
520 |
Hamburg | 128.40 | ![]() |
40 |
gettex | 128.000 | ![]() |
25 |
Düsseldorf | 127.90 | ![]() |
21 |
Vienna Globa.. | 127.90 | ![]() |
0 |
Hannover | 128.50 | ![]() |
0 |
Berlin | 128.50 | ![]() |
0 |
SIX Swiss Ex.. | 102.00 | ![]() |
|
Nasdaq Other.. | 138.0000 | 500 | |
EUREX | Options |
News
- MOR106 clinical development in atopic dermatitis stopped for futility
10/28/2019 / 21:45 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:02 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:01 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:04 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:01 - GlobeNewswire